VPAC1 receptor (vipr_carau)
FAMILY
Class B1 (Secretin) Peptide receptors VIP and PACAP receptors VPAC1 receptor
GENE
vipr1
ORGANISM
Goldfish (Carassius auratus)
ALT. NAMES
Vasoactive intestinal polypeptide receptor, VIP receptor, VIP-R
SOURCE
SWISSPROT
SEQUENCE
N-term | |||||||||
M
|
C
|
D
|
V
|
V
|
N
|
E
|
I
|
E
|
L
|
10 |
A
|
R
|
A
|
R
|
C
|
E
|
N
|
K
|
T
|
A
|
20 |
G
|
N
|
V
|
T
|
S
|
G
|
C
|
K
|
G
|
M
|
30 |
W
|
D
|
I
|
I
|
A
|
C
|
W
|
P
|
S
|
A
|
40 |
K
|
V
|
G
|
E
|
H
|
V
|
V
|
I
|
P
|
C
|
50 |
P
|
N
|
Y
|
F
|
R
|
H
|
F
|
S
|
D
|
H
|
60 |
H
|
E
|
G
|
N
|
L
|
S
|
K
|
T
|
C
|
T
|
70 |
A
|
D
|
G
|
W
|
T
|
E
|
M
|
D
|
P
|
M
|
80 |
E
|
I
|
A
|
V
|
Y
|
C
|
G
|
Y
|
N
|
L
|
90 |
TM1 | |||||||||
N
|
G
|
T
|
V
|
D
|
D
|
D
|
S
|
F
|
F
|
100 |
R
|
S
|
V
|
K
|
I
|
G
|
Y
|
T
|
I
|
G
|
110 |
H
|
S
|
V
|
S
|
L
|
I
|
S
|
L
|
T
|
T
|
120 |
A
|
I
|
V
|
I
|
L
|
C
|
M
|
S
|
R
|
K
|
130 |
ICL1 | TM2 | ||||||||
L
|
H
|
C
|
T
|
R
|
N
|
Y
|
I
|
H
|
M
|
140 |
H
|
L
|
F
|
V
|
S
|
F
|
I
|
L
|
K
|
A
|
150 |
I
|
A
|
V
|
F
|
V
|
K
|
D
|
A
|
V
|
L
|
160 |
ECL1 | |||||||||
Y
|
D
|
V
|
I
|
Q
|
E
|
S
|
D
|
N
|
C
|
170 |
TM3 | |||||||||
S
|
T
|
A
|
S
|
V
|
G
|
C
|
K
|
A
|
V
|
180 |
I
|
V
|
F
|
F
|
Q
|
Y
|
C
|
I
|
M
|
A
|
190 |
S
|
F
|
F
|
W
|
L
|
L
|
V
|
E
|
G
|
L
|
200 |
Y
|
L
|
H
|
A
|
L
|
L
|
A
|
V
|
S
|
F
|
210 |
ICL2 | TM4 | ||||||||
F
|
S
|
E
|
R
|
K
|
Y
|
F
|
W
|
W
|
Y
|
220 |
I
|
L
|
I
|
G
|
W
|
G
|
G
|
P
|
T
|
I
|
230 |
F
|
I
|
M
|
A
|
W
|
S
|
F
|
A
|
K
|
A
|
240 |
ECL2 | |||||||||
Y
|
F
|
N
|
D
|
V
|
G
|
C
|
W
|
D
|
I
|
250 |
TM5 | |||||||||
I
|
E
|
N
|
S
|
D
|
L
|
F
|
W
|
W
|
I
|
260 |
I
|
K
|
T
|
P
|
I
|
L
|
A
|
S
|
I
|
L
|
270 |
M
|
N
|
F
|
I
|
L
|
F
|
I
|
C
|
I
|
I
|
280 |
R
|
I
|
L
|
R
|
Q
|
K
|
I
|
N
|
C
|
P
|
290 |
ICL3 | TM6 | ||||||||
D
|
I
|
G
|
R
|
N
|
E
|
S
|
N
|
Q
|
Y
|
300 |
S
|
R
|
L
|
A
|
K
|
S
|
T
|
L
|
L
|
L
|
310 |
I
|
P
|
L
|
F
|
G
|
I
|
N
|
F
|
I
|
I
|
320 |
ECL3 | |||||||||
F
|
A
|
F
|
I
|
P
|
E
|
N
|
I
|
K
|
T
|
330 |
TM7 | |||||||||
E
|
L
|
R
|
L
|
V
|
F
|
D
|
L
|
I
|
L
|
340 |
G
|
S
|
F
|
Q
|
G
|
F
|
V
|
V
|
A
|
V
|
350 |
H8 | |||||||||
L
|
Y
|
C
|
F
|
L
|
N
|
G
|
E
|
V
|
Q
|
360 |
A
|
E
|
I
|
K
|
R
|
K
|
W
|
R
|
R
|
W
|
370 |
H
|
L
|
E
|
R
|
F
|
L
|
G
|
P
|
D
|
T
|
380 |
C-term | |||||||||
K
|
Y
|
Q
|
H
|
P
|
S
|
M
|
G
|
S
|
N
|
390 |
G
|
N
|
N
|
F
|
S
|
T
|
Q
|
I
|
S
|
M
|
400 |
L
|
T
|
R
|
C
|
S
|
P
|
K
|
T
|
R
|
R
|
410 |
A
|
S
|
T
|
C
|
Q
|
D
|
E
|
T
|
S
|
I
|
420 |
T
|
V
|
L
|
G
|
S
|
T
|
T
|
M
|
G
|
Y
|
430 |
G
|
H
|
Q
|
N
|
E
|
T
|
V
|
K
|
G
|
H
|
440 |
E
|
D
|
V
|
R
|
E
|
V
|
S
|
LINKS
DIAGRAMS
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
ENDOGENOUS LIGANDS
No endogenous ligands available
STRUCTURE MODELS
No structure models available. Check the Archive on Structure models for earlier releases.
STRUCTURES
No structures available